Literature DB >> 27535757

Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers.

Roberto Angioli1, Francesco Plotti1, Stella Capriglione2, Giuseppe Scaletta1, Nella Dugo1, Alessia Aloisi1, Claudia Lucia Piccolo3, Riccardo Del Vescovo3, Corrado Terranova1, Bruno Beomonte Zobel3.   

Abstract

OBJECTIVE: The aim of this study is to prospectively evaluate and compare the accuracy of high-frequency TVS and of two type of MRI (dynamic contrast-enhanced MRI or diffusion-weighted MRI), in association with HE4 in preoperative endometrial cancer (EC) staging. STUDY
DESIGN: Starting from January 2012 to February 2015, all patients with EC at prior endometrial biopsy, referred to the Division of Gynaecologic Oncology of the University Campus Bio-Medico of Rome, were prospectively included in the study. All of them underwent complete surgical staging hysterectomy and bilateral oophorectomy, pelvic and lumboaortic lymphadenectomy, according to 2011 NCCN guidelines. The day before surgery, patients underwent to transvaginal ultrasonography (TVS), HE4 serum dosage, and using a computer-based random procedure, to dynamic contrast-enhanced MRI (Group A) or to diffusion-weighted MRI (Group B), to assess myometrial invasion and cervical involvement.
RESULTS: Starting from January 2012 to February 2015, a total of 79 patients were considered for the analysis and randomly divided into Group A (n = 38) and Group B (n = 41). Regarding myometrial invasion, MRI and TVS resulted comparable in terms of preoperative detection. Concerning the cervical infiltration, the association between TVS and HE4 is characterized by a better preoperative diagnostic validity (TVS + HE4 96.3 vs. 91 % for MRI and 85 % for the TVS).
CONCLUSION: Our results, even the low number of enrolled patients, are promising and may lead to a greater efficiency and lower health care costs in identifying those women who require radical surgery and pelvic lymphadenectomy and should be addressed, in specialized centers.

Entities:  

Keywords:  Endometrial cancer; HE4; Magnetic resonance; Preoperative staging; Ultrasound

Mesh:

Substances:

Year:  2016        PMID: 27535757     DOI: 10.1007/s00404-016-4181-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

1.  Laparoscopic management of uncommon benign uterine tumors: a systematic review.

Authors:  Zaki Sleiman; Sara Hussein; Amani Mohsen; Aline Khazzaka; Alessandro Tropea; Antonio Biondi
Journal:  Updates Surg       Date:  2019-04-02

Review 2.  Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.

Authors:  Stella Capriglione; Daniela Luvero; Francesco Plotti; Corrado Terranova; Roberto Montera; Giuseppe Scaletta; Teresa Schirò; Gianmarco Rossini; Pierluigi Benedetti Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2017-08-20       Impact factor: 3.064

3.  The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.

Authors:  Marco Benati; Martina Montagnana; Elisa Danese; Elisa Paviati; Silvia Giudici; Orazio Ruzzenente; Massimo Franchi; Giuseppe Lippi
Journal:  J Clin Lab Anal       Date:  2017-04-04       Impact factor: 2.352

4.  Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset.

Authors:  Francesco Plotti; Stella Capriglione; Corrado Terranova; Roberto Montera; Giuseppe Scaletta; Salvatore Lopez; Daniela Luvero; Antonelli Gianina; Alessia Aloisi; Pierluigi Benedetti Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2017-04-07       Impact factor: 3.064

5.  Management of postoperative chylous ascites after surgery for ovarian cancer: a single-institution experience.

Authors:  Giuseppe Scaletta; Lorena Quagliozzi; Stefano Cianci; Virginia Vargiu; Maria Cristina Mele; Giovanni Scambia; Anna Fagotti
Journal:  Updates Surg       Date:  2019-04-20

6.  Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging.

Authors:  Yu Guo; Ping Wang; Penghui Wang; Wei Gao; Fenge Li; Xueling Yang; Hongyan Ni; Wen Shen; Zhi Guo
Journal:  Onco Targets Ther       Date:  2017-12-15       Impact factor: 4.147

7.  Diagnostic Accuracy of MRI for Detecting Cervical Invasion in Patients with Endometrial Carcinoma: A Meta-Analysis.

Authors:  Qiu Bi; Guoli Bi; Junna Wang; Jie Zhang; Hongliang Li; Xiarong Gong; Lixiang Ren; Kunhua Wu
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

8.  Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer.

Authors:  Roya Behrouzi; Neil A J Ryan; Chloe E Barr; Abigail E Derbyshire; Y Louise Wan; Zoe Maskell; Katie Stocking; Philip W Pemberton; James Bolton; Rhona J McVey; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2020-01-23       Impact factor: 6.639

9.  Qualitative and quantitative comparison of image quality between single-shot echo-planar and interleaved multi-shot echo-planar diffusion-weighted imaging in female pelvis.

Authors:  He An; Xiaodong Ma; Ziyi Pan; Hua Guo; Elaine Yuen Phin Lee
Journal:  Eur Radiol       Date:  2019-12-10       Impact factor: 5.315

10.  Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?

Authors:  Aneta Cymbaluk-Płoska; Paula Gargulińska; Michał Bulsa; Sebastian Kwiatkowski; Anita Chudecka-Głaz; Kaja Michalczyk
Journal:  Diagnostics (Basel)       Date:  2021-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.